NCBiotech News

We work hard to bring you news about North Carolina’s wide-ranging life sciences community. Please feel free to share it with others. And let us know if you have something we should know about.

Navigating the maze of 20 different organizations that approve military technology projects for funding can be daunting. The 2019 Support to the Warfighter Symposium speakers offered some roadmaps for submitting successful project proposals.
RTP's CivaTech Oncology has some rare good news about pancreatic cancer.
Durham’s Mycovia Pharmaceuticals and Jiangsu Hengrui Medicine of China have announced a collaboration to develop and commercialize Mycovia’s drug candidate for treating recurrent yeast infections in women.
Sage Therapeutics, a Boston-area biopharmaceutical company, has declared Raleigh its “second home” while opening a groundbreaking patient-support headquarters here called Sage Central.
Military procurement leaders at the 2019 Medical, Biomedical, & Biodefense Support to the Warfigher Symposium said the U.S. Joint Forces Command are actively seeking private sector partners to develop new and innovative technology to support the health and healing of U.S. warfighters and veterans.
When Chiesi USA moved into its new 55,000-square-foot headquarters in Cary earlier this year, executives of the specialty pharmaceutical company made sure there was extra space for long-term growth.
Durham's Bioventus is teaming with MTF Biologics, the largest tissue bank in the world, to develop newborns' placental tissue for knee injections to treat osteoarthritis.
A $200,000 NCBiotech grant to a UNC research lab in 2016 has led to new understanding of how the brain drives binge eating.
Xona Microfluidics, a unique cell-culture systems company with an R&D lab in Durham, is ramping up operations with two new products used by neuroscientists to study diseases such as Alzheimer’s and epilepsy.
Burlington-based LabCorp is offering a new assay to help doctors monitor drug responses in patients taking Certolizumab, a biologic therapy for certain inflammatory diseases such as rheumatoid arthritis and Crohn’s disease.
The road to better health is only a simple blood test away, thanks to a new consumer wellness package offered by Burlington-based global life sciences company LabCorp.
Patients wanting easy access to their lab test results from LabCorp can now get them through their smart phones.
Burlington-based global life science company LabCorp and AstraZeneca subsidiary Definiens have announced a collaboration to speed the development of precision medicines.
A $100,000 Economic Development Award (EDA) from the North Carolina Biotechnology Center will boost bioscience industry growth in Burlington and Alamance County.
LabCorp, the Burlington-based diagnostics and drug-development conglomerate, will add digital workflows into its anatomic pathology services under a new collaboration with Royal Philips, a global health technology company.
scroll back to top of page